Australia markets closed

Prestige BioPharma Limited (950210.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
8,890.00+160.00 (+1.83%)
At close: 03:30PM KST
Currency in KRW

Valuation measures4

Market cap (intra-day) 524.64B
Enterprise value 354.31B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.24
Enterprise value/revenue 2.19k
Enterprise value/EBITDA -4.44

Trading information

Stock price history

Beta (5Y monthly) 1.14
52-week change 3-23.02%
S&P500 52-week change 327.86%
52-week high 314,920.00
52-week low 37,940.00
50-day moving average 38,499.00
200-day moving average 39,922.30

Share statistics

Avg vol (3-month) 353.05k
Avg vol (10-day) 362.3k
Shares outstanding 560.1M
Implied shares outstanding 662.53M
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.02%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-15,866.86%

Management effectiveness

Return on assets (ttm)-6.94%
Return on equity (ttm)-12.23%

Income statement

Revenue (ttm)348.79M
Revenue per share (ttm)5.80
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -62.14B
Net income avi to common (ttm)-46.03B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)256.76B
Total cash per share (mrq)21,357.4
Total debt (mrq)111.66B
Total debt/equity (mrq)21.83%
Current ratio (mrq)1.96
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-50.58B
Levered free cash flow (ttm)-57.14B